Cargando…

Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis

BACKGROUND: Existing data evaluating the impact of metformin on the colorectal adenoma (CRA) risk in patients suffering from type 2 diabetes (T2D) are limited and controversial. We therefore summarized the studies currently available and assessed the relationship between metformin treatment and risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Yi-Chao, Hu, Qiang, Huang, Jiao, Fang, Jing-Yuan, Xiong, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352447/ https://www.ncbi.nlm.nih.gov/pubmed/27903961 http://dx.doi.org/10.18632/oncotarget.13633

Ejemplares similares

Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
por: Liu, Feifei, et al.
Publicado: (2016)

Inhibitory Effect of Metformin Therapy on the Incidence of Colorectal Advanced Adenomas in Patients With Diabetes
por: Kim, Yo Han, et al.
Publicado: (2015)

Different effects of metformin and insulin on primary and secondary chemoprevention of colorectal adenoma in diabetes type 2: Traditional and Bayesian meta-analysis
por: Mansourian, Marjan, et al.
Publicado: (2018)

Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis
por: Hou, Yi-Chao, et al.
Publicado: (2017)

Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
por: Zhang, Zhi-Jiang, et al.
Publicado: (2011)

Does Metformin Affect The Incidence of Colonic Polyps and Adenomas in Patients with Type 2 Diabetes Mellitus?
por: Cho, Youn Hee, et al.
Publicado: (2014)

Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies
por: Yu, Feifei, et al.
Publicado: (2016)

Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy
por: Ottaviano, Lorenzo F., et al.
Publicado: (2020)

Intestinal Microbiota in Colorectal Adenoma-Carcinoma Sequence
por: Hua, Hanju, et al.
Publicado: (2022)

Itraconazole induces apoptosis and cell cycle arrest via inhibiting Hedgehog signaling in gastric cancer cells
por: Hu, Qiang, et al.
Publicado: (2017)

People with low serum folate levels have higher risk of colorectal adenoma/advanced colorectal adenoma occurrence and recurrence in China
por: Ding, Hui, et al.
Publicado: (2016)

Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
por: Huang, Qi-You, et al.
Publicado: (2020)

Colorectal adenomas and diabetes: implications for disease prevention
por: Steele, R. J. C., et al.
Publicado: (2015)

Obesity, diabetes and the risk of colorectal adenoma and cancer
por: Soltani, Ghodratollah, et al.
Publicado: (2019)

Association of tea and its extracts with colorectal adenomas: meta-analysis and systematic review
por: Guan, Xifei, et al.
Publicado: (2023)

Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer
por: Dimberg, Jan, et al.
Publicado: (2022)

The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus
por: Tarhini, Zeinab, et al.
Publicado: (2022)

Metformin and Colorectal Cancer Risk in Diabetic Patients
por: Ioannou, George N., et al.
Publicado: (2011)

Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
por: Meng, Fanqiang, et al.
Publicado: (2017)

A new perspective on metformin therapy in type 1 diabetes
por: Livingstone, Rachel, et al.
Publicado: (2017)

Therapy of Type 2 diabetes: more gliflozines and less metformin?
por: Verdecchia, Paolo, et al.
Publicado: (2023)

Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis
por: Hu, Jiao, et al.
Publicado: (2018)

Metformin therapy and cognitive dysfunction in patients with type 2 diabetes: A meta-analysis and systematic review
por: Zhang, Qing-Qing, et al.
Publicado: (2020)

Legume Consumption and Colorectal Adenoma Risk: A Meta-Analysis of Observational Studies
por: Wang, Yunqian, et al.
Publicado: (2013)

Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
por: Zhang, Yanfei, et al.
Publicado: (2013)

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
por: Garrett, C R, et al.
Publicado: (2012)

Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus
por: Saito, Akira, et al.
Publicado: (2020)

Comparison of the Efficacy and Safety of Metformin-Based Combination Therapy Versus Metformin Alone in Children and Adolescents With Type 2 Diabetes Mellitus: A Meta-Analysis
por: Khan, Raza A, et al.
Publicado: (2023)

Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients
por: Wang, Fei, et al.
Publicado: (2017)

Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
por: Mei, Zu-Bing, et al.
Publicado: (2014)

Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial
por: Zhang, Fang, et al.
Publicado: (2021)

Retrospective study of risk factors for colorectal adenomas and non-adenomatous polyps
por: Chao, Guanqun, et al.
Publicado: (2020)

Variation rs9929218 and risk of the colorectal Cancer and adenomas: A meta-analysis
por: Wang, Huiyan, et al.
Publicado: (2021)

The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy
por: Yuan, Bo, et al.
Publicado: (2022)

Metformin and Cancer in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2013)

Metformin and Type 2 Diabetes Prevention
por: Aroda, Vanita R., et al.
Publicado: (2018)

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis
por: Yin, Shinan, et al.
Publicado: (2014)

Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes
por: Singh, Awadhesh K, et al.
Publicado: (2021)

Metformin and Colorectal Cancer
por: Higurashi, Takuma, et al.
Publicado: (2018)

Multiple colorectal adenomas in Lynch syndrome
por: Jain, Ayushi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_krkmjse1v21251fc18tpht4qrf